Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine

Zhengyu Feng, Raúl G. Barletta

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

D-Cycloserine (DCS) targets the peptidoglycan biosynthetic enzymes D-alanine racemase (Air) and D-alanine: D-alanine ligase (Ddl). Previously, we demonstrated that the overproduction of Air in Mycobacterium smegmatis determines a DCS resistance phenotype. In this study, we investigated the roles of both Air and Ddl in the mechanisms of action of and resistance to DCS in M. smegmatis. We found that the overexpression of either the M. smegmatis or the Mycobacterium tuberculosis ddl gene in M. smegmatis confers resistance to DCS, but at lower levels than the overexpression of the alr gene. Furthermore, a strain overexpressing both the alr and ddl genes displayed an eightfold-higher level of resistance. To test the hypothesis that inhibition of Air by DCS decreases the intracellular pool of D-alanine, we determined the alanine pools in M. smegmatis wild-type and recombinant strains with or without DCS treatment. Air-overproducing strain GPM14 cells not exposed to DCS displayed almost equimolar amounts of L- and D-alanine in the steady state. The wild-type strain and Ddl-overproducing strains contained a twofold excess of L- over D-alanine. In all strains, DCS treatment led to a significant accumulation of L-alanine and a concomitant decease of D-alanine, with approximately a 20-fold excess of L-alanine in the Ddl-overproducing strains. These data suggest that Ddl is not significantly inhibited by DCS at concentrations that inhibit Air. This study is of significance for the identification of the lethal target(s) of DCS and the development of novel drugs targeting the D-alanine branch of mycobacterial peptidoglycan biosynthesis.

Original languageEnglish (US)
Pages (from-to)283-291
Number of pages9
JournalAntimicrobial Agents and Chemotherapy
Volume47
Issue number1
DOIs
StatePublished - Jan 1 2003

Fingerprint

Alanine Racemase
Cycloserine
Mycobacterium smegmatis
Peptidoglycan
Alanine
4 alpha-glucanotransferase
D-alanylalanine synthetase
Genes
Drug Delivery Systems
Mycobacterium tuberculosis

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

@article{60e47d2ca754479780ff5d69f5f0c9a8,
title = "Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine",
abstract = "D-Cycloserine (DCS) targets the peptidoglycan biosynthetic enzymes D-alanine racemase (Air) and D-alanine: D-alanine ligase (Ddl). Previously, we demonstrated that the overproduction of Air in Mycobacterium smegmatis determines a DCS resistance phenotype. In this study, we investigated the roles of both Air and Ddl in the mechanisms of action of and resistance to DCS in M. smegmatis. We found that the overexpression of either the M. smegmatis or the Mycobacterium tuberculosis ddl gene in M. smegmatis confers resistance to DCS, but at lower levels than the overexpression of the alr gene. Furthermore, a strain overexpressing both the alr and ddl genes displayed an eightfold-higher level of resistance. To test the hypothesis that inhibition of Air by DCS decreases the intracellular pool of D-alanine, we determined the alanine pools in M. smegmatis wild-type and recombinant strains with or without DCS treatment. Air-overproducing strain GPM14 cells not exposed to DCS displayed almost equimolar amounts of L- and D-alanine in the steady state. The wild-type strain and Ddl-overproducing strains contained a twofold excess of L- over D-alanine. In all strains, DCS treatment led to a significant accumulation of L-alanine and a concomitant decease of D-alanine, with approximately a 20-fold excess of L-alanine in the Ddl-overproducing strains. These data suggest that Ddl is not significantly inhibited by DCS at concentrations that inhibit Air. This study is of significance for the identification of the lethal target(s) of DCS and the development of novel drugs targeting the D-alanine branch of mycobacterial peptidoglycan biosynthesis.",
author = "Zhengyu Feng and Barletta, {Ra{\'u}l G.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1128/AAC.47.1.283-291.2003",
language = "English (US)",
volume = "47",
pages = "283--291",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine

AU - Feng, Zhengyu

AU - Barletta, Raúl G.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - D-Cycloserine (DCS) targets the peptidoglycan biosynthetic enzymes D-alanine racemase (Air) and D-alanine: D-alanine ligase (Ddl). Previously, we demonstrated that the overproduction of Air in Mycobacterium smegmatis determines a DCS resistance phenotype. In this study, we investigated the roles of both Air and Ddl in the mechanisms of action of and resistance to DCS in M. smegmatis. We found that the overexpression of either the M. smegmatis or the Mycobacterium tuberculosis ddl gene in M. smegmatis confers resistance to DCS, but at lower levels than the overexpression of the alr gene. Furthermore, a strain overexpressing both the alr and ddl genes displayed an eightfold-higher level of resistance. To test the hypothesis that inhibition of Air by DCS decreases the intracellular pool of D-alanine, we determined the alanine pools in M. smegmatis wild-type and recombinant strains with or without DCS treatment. Air-overproducing strain GPM14 cells not exposed to DCS displayed almost equimolar amounts of L- and D-alanine in the steady state. The wild-type strain and Ddl-overproducing strains contained a twofold excess of L- over D-alanine. In all strains, DCS treatment led to a significant accumulation of L-alanine and a concomitant decease of D-alanine, with approximately a 20-fold excess of L-alanine in the Ddl-overproducing strains. These data suggest that Ddl is not significantly inhibited by DCS at concentrations that inhibit Air. This study is of significance for the identification of the lethal target(s) of DCS and the development of novel drugs targeting the D-alanine branch of mycobacterial peptidoglycan biosynthesis.

AB - D-Cycloserine (DCS) targets the peptidoglycan biosynthetic enzymes D-alanine racemase (Air) and D-alanine: D-alanine ligase (Ddl). Previously, we demonstrated that the overproduction of Air in Mycobacterium smegmatis determines a DCS resistance phenotype. In this study, we investigated the roles of both Air and Ddl in the mechanisms of action of and resistance to DCS in M. smegmatis. We found that the overexpression of either the M. smegmatis or the Mycobacterium tuberculosis ddl gene in M. smegmatis confers resistance to DCS, but at lower levels than the overexpression of the alr gene. Furthermore, a strain overexpressing both the alr and ddl genes displayed an eightfold-higher level of resistance. To test the hypothesis that inhibition of Air by DCS decreases the intracellular pool of D-alanine, we determined the alanine pools in M. smegmatis wild-type and recombinant strains with or without DCS treatment. Air-overproducing strain GPM14 cells not exposed to DCS displayed almost equimolar amounts of L- and D-alanine in the steady state. The wild-type strain and Ddl-overproducing strains contained a twofold excess of L- over D-alanine. In all strains, DCS treatment led to a significant accumulation of L-alanine and a concomitant decease of D-alanine, with approximately a 20-fold excess of L-alanine in the Ddl-overproducing strains. These data suggest that Ddl is not significantly inhibited by DCS at concentrations that inhibit Air. This study is of significance for the identification of the lethal target(s) of DCS and the development of novel drugs targeting the D-alanine branch of mycobacterial peptidoglycan biosynthesis.

UR - http://www.scopus.com/inward/record.url?scp=0037228454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037228454&partnerID=8YFLogxK

U2 - 10.1128/AAC.47.1.283-291.2003

DO - 10.1128/AAC.47.1.283-291.2003

M3 - Article

C2 - 12499203

AN - SCOPUS:0037228454

VL - 47

SP - 283

EP - 291

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 1

ER -